PCK1 and ablepharon macrostomia syndrome: Additionally, an enzyme related to glycogenesis, PCK1, was identified as a candidate predictive biomarker for AMS in our study, and this finding highlights the potentially important role of gluconeogenesis in the prediction of AMS.